ArticleNeuroradiology2026
A multicenter retrospective cohort study showing that bridging thrombolysis does not achieve better outcomes compared to direct mechanical thrombectomy in stroke due to internal carotid artery occlusion.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Prognostic value of the CALLY index for functional outcomes in acute ischemic stroke: a systematic review and exploratory quantitative synthesis.Frontiers in neurology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
Abstract
background and purposeMechanical thrombectomy (MT) is an effective treatment for patients with acute ischaemic stroke secondary to internal carotid artery (ICA) occlusion. Intravenous thrombolysis (IVT) prior to MT is also commonly administered in suitable patients. This study aimed to compare the outcomes of patients with acute ICA stroke who were treated with direct MT versus combined IVT plus MT. Additionally, analysis was performed in different subgroups of patients such as those with large artery stenosis (LAA) to evaluate which subgroup of patients would benefit most from bridging IVT.
methodsThis multicenter retrospective cohort study included patients who were treated for acute ICA stroke from three comprehensive stroke centers between January 2015 and December 2019. Patients received direct MT or combined bridging IVT plus MT. Primary outcome was favorable functional outcome defined as modified Rankin Scale (mRS) 0-2 measured at 90 days after discharge. Secondary outcome measures included mRS on discharge, inpatient mortality and complications such as symptomatic intracranial hemorrhage (sICH), subarachnoid haemorrhage (SAH) and embolism of thrombus to new territories.
resultsAmong 352 patients, 178 (50.6%) patients underwent bridging IVT followed by MT and 174 (49.4%) underwent direct MT. The mean ± standard deviation age was 69.8 ± 14.6 years, 50.9% were male and median National Institutes of Health Stroke Scale was 16. At 90-days after discharge, patients who underwent bridging IVT had similar functional outcomes as those who underwent direct MT (OR = 1.53; 95% CI 0.68-3.42; p = 0.303). Bridging IVT was also not associated with improvement in discharge mRS score, decreased inpatient mortality, or difference in rate of complications compared to direct MT. In subgroup analyses, patients with underlying atherosclerosis treated with bridging IVT compared to direct MT had a higher rate of favorable functional outcome at 90 days (33.9% vs. 14.0%, p = 0.022).
conclusionsBridging IVT is not associated with better functional outcomes compared to direct MT in ICA stroke. However, in the subgroup of patients with underlying large-artery atherosclerosis stroke mechanism, bridging IVT appears to potentially confer beneficial outcomes. This should be validated in larger studies.
Indexed as
Identifiers
41563403What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.